Janet S. Rader

41.3k total citations · 1 hit paper
210 papers, 8.4k citations indexed

About

Janet S. Rader is a scholar working on Obstetrics and Gynecology, Molecular Biology and Surgery. According to data from OpenAlex, Janet S. Rader has authored 210 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Obstetrics and Gynecology, 59 papers in Molecular Biology and 56 papers in Surgery. Recurrent topics in Janet S. Rader's work include Endometrial and Cervical Cancer Treatments (61 papers), Cervical Cancer and HPV Research (50 papers) and Ovarian cancer diagnosis and treatment (46 papers). Janet S. Rader is often cited by papers focused on Endometrial and Cervical Cancer Treatments (61 papers), Cervical Cancer and HPV Research (50 papers) and Ovarian cancer diagnosis and treatment (46 papers). Janet S. Rader collaborates with scholars based in United States, Canada and United Kingdom. Janet S. Rader's co-authors include David G. Mutch, Randall K. Gibb, Perry W. Grigsby, Thomas J. Herzog, Matthew A. Powell, Farrokh Dehdashti, Paul J. Goodfellow, Barry A. Siegel, Matthew A. Powell and Jason D. Wright and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Janet S. Rader

205 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth

2008 615 citations Xiaohong Wang, Shuang Tang et al. PLoS ONE profile →

Peers

Countries citing papers authored by Janet S. Rader

Since Specialization

Citations

This map shows the geographic impact of Janet S. Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet S. Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet S. Rader more than expected).

Fields of papers citing papers by Janet S. Rader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet S. Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet S. Rader. The network helps show where Janet S. Rader may publish in the future.

Co-authorship network of co-authors of Janet S. Rader

This figure shows the co-authorship network connecting the top 25 collaborators of Janet S. Rader. A scholar is included among the top collaborators of Janet S. Rader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet S. Rader. Janet S. Rader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deciphering the divergent transcriptomic landscapes of cervical cancer cells grown in 3D and 2D cell culture systems 2024 ·Frontiers in Cell and Developmental Biology ·Roshan Kumar, (unknown), Shirng‐Wern Tsaih, (unknown), Akinyemi I. Ojesina, Janet S. Rader	6
2	Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult‐type ovarian granulosa cell tumors 2024 ·Cancer Medicine ·(unknown), Erica Gornstein, (unknown), (unknown), Janet S. Rader, (unknown)	0
3	A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors 2023 ·Targeted Oncology ·Todd M. Bauer, Kathleen N. Moore, Janet S. Rader, Fiona Simpkins, Alain C. Mita, J. Thaddeus Beck, Lowell L. Hart, Quincy S. Chu, Amit M. Oza, Anna V. Tinker, (unknown), Sanjeev Kumar, Ganesh Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F. Jones, David R. Spigel, Siqing Fu	21
4	PO13 2023 ·Brachytherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Erin Bishop, (unknown), William H. Bradley, Denise Uyar, Janet S. Rader, Meena Bedi, Bradley A. Erickson	1
5	Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling 2020 ·Cancer Research ·Deepak Parashar, (unknown), Anjali Geethadevi, Jasmine George, Ajay Nair, Shirng‐Wern Tsaih, (unknown), Gopa Kumar Gopinadhan Nair, Yiling Lu, Ramani Ramchandran, Denise Uyar, Janet S. Rader, Prahlad T. Ram, Gordon B. Mills, Sunila Pradeep, Pradeep Chaluvally–Raghavan	29
6	SOX11 hypermethylation as a tumor biomarker in endometrial cancer 2019 ·Biochimie ·(unknown), Denise Uyar, Li-Shu Wang, David G. Mutch, Tim H.‐M. Huang, Janet S. Rader, Xiugui Sheng, Yi‐Wen Huang	15
7	Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Pengyuan Liu, (unknown), Samantha Fye, Yi‐Wen Huang, (unknown), Chu Chen, Yan Lü, Janet S. Rader	19
8	A MicroRNA Expression Signature for Cervical Cancer Prognosis 2010 ·Cancer Research ·Xiaoxia Hu, Julie K. Schwarz, James S. Lewis, Phyllis C. Huettner, Janet S. Rader, Joseph O. Deasy, Perry W. Grigsby, Xiaowei Wang	247
9	Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer 2009 ·Gynecologic Oncology ·Rebecca Brooks, Nora T. Kizer, Loan Nguyen, (unknown), Karolyn A. Wanat, Elizabeth Nugent, Perry W. Grigsby, Jenifer E. Allsworth, Janet S. Rader	24
10	CD83 polymorphisms and cervical cancer risk 2009 ·Gynecologic Oncology ·Kelly J. Yu, Janet S. Rader, Ingrid B. Borecki, Zhengyan Zhang, Allan Hildesheim	16
11	Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 2009 ·RNA ·Xiaohong Wang, Hsu-Kun Wang, J. Philip McCoy, N. Sanjib Banerjee, Janet S. Rader, Thomas R. Broker, Craig Meyers, Louise T. Chow, Zhi‐Ming Zheng	195
12	Effects of cancer treatment on ovarian function 2008 ·Fertility and Sterility ·(unknown), David G. Mutch, Janet S. Rader, (unknown), Premal H. Thaker, Perry W. Grigsby	68
13	Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth breakdown → 2008 ·PLoS ONE ·Xiaohong Wang, Shuang Tang, (unknown), Robert Lu, Janet S. Rader, Craig Meyers, Zhi‐Ming Zheng	615
14	Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates 2007 ·Cancer Research ·David Gius, (unknown), Eric Y. Chuang, Sheng Feng, Phyllis C. Huettner, Loan Nguyen, C. Matthew Bradbury, Mark V. Mishra, Shuping Gao, Barbara M. Buttin, David E. Cohn, Matthew A. Powell, Neil S. Horowitz, Bradford P. Whitcomb, Janet S. Rader	76
15	FDG-PET evaluation of vaginal carcinoma 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Wayne T. Lamoreaux, Perry W. Grigsby, Farrokh Dehdashti, Imran Zoberi, Matthew A. Powell, Randall K. Gibb, Janet S. Rader, David G. Mutch, Barry A. Siegel	60
16	Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. 2003 ·PubMed ·Bradford P. Whitcomb, David G. Mutch, Thomas J. Herzog, Janet S. Rader, Randall K. Gibb, Paul J. Goodfellow	86
17	A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study 2003 ·Investigational New Drugs ·Deborah K. Armstrong, John A. Blessing, Janet S. Rader, Joel I. Sorosky	16
18	Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix 2001 ·Human Pathology ·Maureen J. O’Sullivan, Janet S. Rader, Daniela S. Gerhard, Yan Li, Kathryn Trinkaus, Deborah J. Gersell, Phyllis C. Huettner	13
19	Clinical significance of microsatellite instability in endometrial carcinoma 2000 ·Cancer ·Jack Basil, Paul J. Goodfellow, Janet S. Rader, David G. Mutch, Thomas J. Herzog	89
20	Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. 1999 ·PubMed ·(unknown), Sergio Marchini, Janet S. Rader, Alonso Martínez, Donia Macartney‐Coxson, Massimo Broggini, Maria Cristina Morelli, Giuseppe Barbanti‐Brodano, Eamonn R. Maher, Farida Latif	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact